|
Zeo Scientifix Inc (BPSR) |
|
Zeo Scientifix Inc
BPSR's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Zeo Scientifix Inc 's sales fell
by -5.55 % in I. Quarter 2025 from the same quarter a year ago.
Ranking at No. 1618
Biotechnology & Pharmaceuticals industry recorded
deterioration of revenues by -2.45 %
Zeo Scientifix Inc net loss increased from $-1 millions, to $-1 millions in I. Quarter 2025,
• More on BPSR's Growth
|
|
Zeo Scientifix Inc realized a net loss in trailing twelve months.
Zeo Scientifix Inc realized cash reduction of $ -0.07 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.08.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.14.
• More on BPSR's Valuation
|
|
|
|
|
Zeo Scientifix Inc realized net loss in trailing twelve months.
Zeo Scientifix Inc realized cash outflow of $ -0.07per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.08.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.14.
• More on BPSR's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com